Development and Characterization of Pharmaceutical-Grade Eudragit® L100 Filaments for FDM 3D Printing of Solid Oral Dosage Forms
Abstract
Fused Deposition Modeling (FDM) three-dimensional printing is an emerging technology in pharmaceutical technology, offering significant opportunities for treatment personalization and precise control of drug release profiles. However, one of the major technological limitations remains the availability of filaments specifically designed for pharmaceutical applications, as an alternative to conventional plastic polymers such as PLA or ABS. The present study aims to develop pharmaceutical-grade filaments suitable for FDM 3D printing using authorized excipients, and to evaluate their physicochemical and biopharmaceutical properties. Formulations based on Eudragit® L100, plasticized with glycerin or butyl phthalate, were prepared by extrusion using a semi-artisanal shaping process.
The resulting filaments were characterized in terms of appearance, hardness, mechanical resistance to breakage, and drug release profiles of two model compounds, methylene blue and ibuprofen, in simulated gastrointestinal media. The results demonstrate that Eudragit® L100 enables the production of filaments exhibiting a satisfactory balance between rigidity and flexibility, compatible with FDM 3D printing requirements. Release studies revealed a preferential drug release in simulated intestinal medium, confirming the pH-dependent behavior of the polymer. These findings demonstrate the feasibility of developing functional pharmaceutical filaments and highlight the potential of additive manufacturing for the production of personalized oral dosage forms.
Keywords: Pharmaceutical 3D printing; Fused Deposition Modeling (FDM); pharmaceutical filaments; Eudragit® L100; pH-dependent drug release.
Keywords:
Pharmaceutical 3D printing, pharmaceutical filaments, EudragitL100DOI
https://doi.org/10.22270/jddt.v16i2.7570References
1. Anepc G, Aulagner G, Bedouch P, Sautou-Miranda V. Pharmacie clinique et dispositifs médicaux. Elsevier Health Sciences; 2023.
2. Bochot A, Chambin O, Pillon F. Improving oral bioavailability. Asian Journal of Pharmaceutics. 2011;50:10-11. https://doi.org/10.1016/S0515-3700(11)71015-1
3. Bonnemain B, Puisieux F. History of modified-release oral dosage forms. Revue d'Histoire de la Pharmacie. 2005;93:33-44. https://doi.org/10.3406/pharm.2005.5758 PMid:16021753
4. Breton A, et al. Pharmaceutical 3D printing: A review. International Journal of Pharmaceutics. 2020;586:119594. https://doi.org/10.1016/j.ijpharm.2020.119594 PMid:32622811
5. Chen G, Xu Y, Kwok PCL, Kang L. Pharmaceutical applications of 3D printing. Journal of Controlled Release. 2020;328:45-67. https://doi.org/10.1016/j.addma.2020.101209
6. Dhinesh SK, et al. Mechanical behavior of PLA and ABS materials. Materials Today: Proceedings. 2021;45:1175-1180. https://doi.org/10.1016/j.matpr.2020.03.546
7. Draï A, Aour B. Effect of temperature on thermoplastics. CSMA Proceedings. 2015.
8. Goyanes A, et al. FDM 3D printing for oral drug delivery. International Journal of Pharmaceutics. 2014;476:88-92. https://doi.org/10.1016/j.ijpharm.2014.09.044 PMid:25275937
9. Goyanes A, et al. 3D printed modified-release dosage forms. European Journal of Pharmaceutics and Biopharmaceutics. 2015;89:157-164. https://doi.org/10.1016/j.ejpb.2014.12.003 PMid:25497178
10. Goyanes A, et al. Fused filament fabrication of medicines. International Journal of Pharmaceutics. 2017;527:21-30. https://doi.org/10.1016/j.ijpharm.2017.05.021 PMid:28502898
11. Gourraud PA, et al. 3D printing during COVID-19 crisis. Médecine de Catastrophe. 2020;4:233-240. https://doi.org/10.1016/j.pxur.2020.08.017 PMCid:PMC7538074
12. Greive K. Glycerine as humectant. Dermatological Nursing. 2012;11:30-34.
13. Jamróz W, et al. 3D printing in pharmaceutical technology. European Journal of Pharmaceutics and Biopharmaceutics. 2018;131:186-195. https://doi.org/10.1016/j.ejpb.2018.07.017 PMid:30048746
14. Khaled SA, et al. 3D printing of tablets. International Journal of Pharmaceutics. 2015;494:643-650. https://doi.org/10.1016/j.ijpharm.2015.07.067 PMid:26235921
15. Khaled SA, et al. Personalized medicines via 3D printing. Journal of Controlled Release. 2018;279:12-24.
16. Le Hir A, Chaumeil JC, Brossard D. Pharmacie galénique. Elsevier Masson; 2011.
17. Norman J, et al. Pharmaceutical manufacturing by 3D printing. Advanced Drug Delivery Reviews. 2017;108:39-50. https://doi.org/10.1016/j.addr.2016.03.001 PMid:27001902
18. Pietrzak K, et al. Pharmaceutical hot-melt extrusion. Drug Development and Industrial Pharmacy. 2015;41:1706-1718.
19. Prasad LK, Smyth H. 3D printing technologies in drug delivery. Advanced Drug Delivery Reviews. 2016;108:1-5.
20. Rahman Z, et al. FDA perspective on 3D printed drugs. AAPS PharmSciTech. 2018;19:17-25.
21. Rattanakit P, et al. Eudragit-based drug delivery systems. Pharmaceutics. 2019;11:458. https://doi.org/10.3390/pharmaceutics11060290 PMid:31226748 PMCid:PMC6630634
22. Roy P, Shahiwala A. Multiparticulate drug delivery. Journal of Controlled Release. 2009;134:74-80. https://doi.org/10.1016/j.jconrel.2008.11.011 PMid:19105973
23. Salazar V, et al. Toxicity of dibutyl phthalate. Toxicology. 2004;205:131-137. https://doi.org/10.1016/j.tox.2004.06.045 PMid:15458798
24. Sandler N, Preis M. Printed drugs. Trends in Pharmacological Sciences. 2016;37:107-118. https://doi.org/10.1016/j.tips.2016.10.002 PMid:27992318
25. Scoutaris N, et al. FDM printed dosage forms. International Journal of Pharmaceutics. 2018;544:284-296.
26. Swarbrick J. Drug delivery: Controlled release. CRC Press; 2013.
27. Thakral S, Thakral NK, Majumdar DK. Eudragit® technology: Evaluation and future prospects. Expert Opinion on Drug Delivery. 2013;10:131-149. https://doi.org/10.1517/17425247.2013.736962 PMid:23102011
28. Trenfield SJ, et al. Printing medicines in hospital pharmacies. International Journal of Pharmaceutics. 2018;546:197-207.
29. Trenfield SJ, et al. Personalized drug delivery via 3D printing. Advanced Drug Delivery Reviews. 2019;143:130-145. https://doi.org/10.1016/j.addr.2019.04.005 PMid:31004625
30. Ventola CL. Medical applications for 3D printing. P&T. 2014;39:704-711
Published
Abstract Display: 143 
PDF Downloads: 98 PDF Downloads: 26 How to Cite
Issue
Section
Copyright (c) 2026 Sidy Mouhamed Dieng , Gora Mbaye , Louis Augustin Diouf , Mouhamed Mbaye , Maguate Ndiaye , Papa Mady Sy , Sandra Tefouemewe , Abdou Faye , Marie Jeanne Arlette Ciss , Mounibe Diarra
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.